Clinical Trial: Intralipid for Recurrent Miscarriage
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: The Role of Intralipid in Natural Killer Cell Positive Cases With Recurrent Miscarriages Undergoing IVF/ICSI Cycles: a Double Blind Randomized Controlled Trial
Brief Summary: Intralipid infusion can improve the outcome in NK cells positive females with history of recurrent miscarriages undergoing IVF/ICSI cycles.
Detailed Summary:
Sponsor: Woman's Health University Hospital, Egypt
Current Primary Outcome: chemical pregnancy rate [ Time Frame: 10 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: clinical pregnancy rate, [ Time Frame: 10 months ]
Original Secondary Outcome: Same as current
Information By: Woman's Health University Hospital, Egypt
Dates:
Date Received: February 7, 2013
Date Started: February 2013
Date Completion: September 2015
Last Updated: May 31, 2015
Last Verified: May 2015